⌘K

Login Start Free

Home/Filings/4/0000950170-25-010116

4//SEC Filing

Powl Brian T. 4

Accession 0000950170-25-010116

CIK 0001422143other

View on SEC.gov Company Profile

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 8:38 PM ET

Size

4.7 KB

Accession

0000950170-25-010116

Insider Transaction Report

Form 4

Period: 2025-01-28

Kura Oncology, Inc.KURA

Chief Commercial Officer

Transactions

Sale
Common Stock
2025-01-28$7.87/sh−1,583$12,461→ 59,667 total

Footnotes (1)

[F1]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Kura Oncology, Inc.

CIK 0001422143

Entity typeother

Related Parties

1

filerCIK 0001934232

Filing Metadata

Form type: 4
Filed: Jan 27, 7:00 PM ET
Accepted: Jan 28, 8:38 PM ET
Size: 4.7 KB

View on SEC.gov